Immediate Impact

1 by Nobel laureates 3 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study
2023 Standout
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
2022 Standout
2 intermediate papers

Works of Peter M. Krahn being referenced

Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations
1997
The mephenytoin (cytochrome P450 2C 19) and dextromethorphan (cytochrome P450 2D6) polymorphisms in Saudi Arabians and Filipinos
1995

Author Peers

Author Last Decade Papers Cites
Peter M. Krahn 17 37 13 210 103 7 429
Hiromi Fukushima‐Uesaka 3 16 15 245 225 16 483
MJ Langman 1 5 22 109 106 11 421
Leif Bertilsson 4 9 321 131 9 490
C. G. Reg�rdh 3 3 229 144 12 405
E. Wåhlin 8 3 99 43 12 468
Chang-Hong Jiang 2 3 30 176 107 13 470
Josephine A. Procknal 1 8 29 117 42 15 511
Joanna Chowdry 4 8 12 176 110 13 384
Margareta Hammarlund 18 10 60 53 8 376
Ming-Liang Lai 9 11 185 255 16 505

All Works

Loading papers...

Rankless by CCL
2026